370
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

Asbestos: Mineralogical features and fiber analysis in biological materials

&
Pages 369-378 | Received 26 May 2023, Accepted 23 Sep 2023, Published online: 06 Oct 2023

References

  • Mendes R. Chemical Hazards. In: Guidotti TL, ed. Global Occupational Health. New York, NY: Oxford University Press; 2011. p. 158–171.
  • Mossman BT, Bignon J, Corn M, Seaton A, Gee JB. Asbestos: Scientific developments and implications fır public policy. Science. 1990;247(4940):294–301. doi:10.1126/science.2153315.
  • Turkey Asbestos Control Strategic Plan Final Report [published correction appears in Turk Thorac J. 2018 Jan;19(1):52]. Turk Thorac J. 2015;16(Suppl 2):S27–S52. doi:10.5152/ttd.2015.10120136.
  • Pass HI, Carbone M, Krug LM, et al. Bening and Malignant Mesothelioma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Philadelphia, PA: Wolters Kluver Publisher; 2019. p. 3274–3316.
  • Le Bouffant L. Investigation and analysis of asbestos fibers and accompanying minerals in biological materials. Environ Health Perspect. 1974;9:149–153. doi:10.1289/ehp.749149.
  • De Vuyst P, Karjalainen A, Dumortier P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society. Eur Respir J. 1998;11(6):1416–1426. doi:10.1183/09031936.98.11061416.
  • Craighead JE, Gibbs A, Pooley F. Mineralogy of Asbestos. In: Craighead JE, Gibbs AR, eds. Asbestos and Its Diseases. New York, NY: Oxford University Press; 2008. p. 23–38.
  • Malcolm R. The geologic occurrences and health hazards of amphibole and serpentine asbestos. In: Rigari FL, ed. The Asbestos Minerals. Michigan, MI: Malbrown; 1991. p. 279–319.
  • Senyiğit A, Babayiğit C, Gökirmak M, et al. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey. Respiration. 2000;67(6):610–614. doi:10.1159/000056289.
  • Metintas M, Metintas S, Ak G, et al. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology. 2008;13(1):117–121. doi:10.1111/j.1440-1843.2007.01187.x.
  • Boulanger G, Andujar P, Pairon JC, et al. Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity. Environ Health. 2014;13(1):59. doi:10.1186/1476-069X-13-59.
  • Pooley FD. Characterization of lung burden E.M.P.S. Toxicol Appl Pharmacol. 2018;361:18–20. doi:10.1016/j.taap.2018.10.019.
  • Schwartz AG, Cote ML. epidemiology of lung cancer. Adv Exp Med Biol. 2016;893:21–41. doi:10.1007/978-3-319-24223-1_2.
  • Ahasic AM, Christiani DC, et al. Respiratory Disorders. In: Levy BS, Wegman DH, Baron SL eds. Occupational and Environmental Health Recognizing and Preventing Disease and Injury. New York, NY: Oxford University Press; 2011. p. 419–422.
  • Akarsu M, Ak G, Dündar E, Metintaş M. Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma. J Cancer Res Clin Oncol. 2023;149(10):7767–7778. doi:10.1007/s00432-023-04730-1.
  • Hillerdal G. The human evidence: parenchymal and pleural changes. Ann Occup Hyg. 1994;38(4):561–417. doi:10.1093/annhyg/38.4.561.
  • Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 1997;23(2):93–103. doi:10.5271/sjweh.186.
  • Churg A. Analysis of asbestos fibers from lung tissue: research and diagnostic uses. Semin Respir Crit Care Med. 1986;7(03):281–288. doi:10.1055/s-2007-1012623.
  • Eccher A, Girolami I, Lucenteforte E, Troncone G, Scarpa A, Pantanowitz L. Diagnostic mesothelioma biomarkers in effusion cytology. Cancer Cytopathol. 2021;129(7):506–516. doi:10.1002/cncy.22398.
  • Girolami I, Lucenteforte E, Eccher A, et al. Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology. Cancer Cytopathol. 2022;130(2):96–109. doi:10.1002/cncy.22509.
  • Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23(4):311–316.
  • Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5–15. doi:10.5271/sjweh.3462.
  • Roggli VL. Human disease consequences of fiber exposures: a review of human lung pathology and fiber burden data. Environ Health Perspect. 1990;88:295–303. doi:10.1289/ehp.9088295.
  • Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010;134(3):462–480. doi:10.5858/134.3.462.
  • Roggli VL, Butnor KJ. Pneumoconiosis. In: Leslie KO, Wick MR, eds. Practical Pulmonary Pathology: A Diagnostic Approach. Philadelphia, PA: Churchill Livingstone; 2005. p. 312–319.
  • Gibbs AR, Pooley FD. Analysis and interpretation of inorganic mineral particles in "lung" tissues. Thorax. 1996;51(3):327–334. doi:10.1136/thx.51.3.327.
  • Crouch E, Churg A. Ferruginous bodies and the histologic evaluation of dust exposure. Am J Surg Pathol. 1984;8(2):109–116. doi:10.1097/00000478-198402000-00004.
  • Roggli V. Asbestos bodies and non-asbestos ferruginous bodies. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of Asbestos-Associated Diseases. Boston, New York, NY: Little Brown; 1992. p. 39–75.
  • Morgan A, Holmes A. The distribution and characteristics of asbestos fibers in the lungs of Finnish anthophyllite mine-workers. Environ Res. 1984;33(1):62–75. doi:10.1016/0013-9351(84)90009-4.
  • Churg A. The distribution of amosite asbestos in the periphery of the normal human lung. Br J Ind Med. 1990;47(10):677–681. doi:10.1136/oem.47.10.677.
  • Churg A, Wood P. Observations on the distribution of asbestos fibers in human lungs. Environ Res. 1983;31(2):374–380. doi:10.1016/0013-9351(83)90015-4.
  • Modin BE, Greenberg SD, Buffler PA, Lockhart JA, Seitzman LH, Awe RJ. Asbestos bodies in a general hospital/clinic population. Acta Cytol. 1982;26(5):667–677.
  • Teschler H, Thompson AB, Dollenkamp R, Konietzko N, Costabel U. Relevance of asbestos bodies in sputum. Eur Respir J. 1996;9(4):680–686. doi:10.1183/09031936.96.09040680.
  • Sebastien P, Armstrong B, Monchaux G, Bignon J. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis. 1988;137(1):75–78. doi:10.1164/ajrccm/137.1.75.
  • Gibbs AR, Stephens M, Griffiths DM, Blight BJ, Pooley FD. Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. Br J Ind Med. 1991;48(11):762–770. doi:10.1136/oem.48.11.762.
  • Churg A, Wiggs B, Depaoli L, Kampe B, Stevens B. Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis. 1984;130(6):1042–1045. doi:10.1164/arrd.1984.130.6.1042.
  • Gibbs AR, Pooley FD. Bits and pieces: asbestos contamination in paraffin tissue blocks. Hum Exp Toxicol. 1996;15:85–86.
  • Lee RJ, Florida RG, Stewart IM. Asbestos contamination in paraffin tissue blocks. Arch Pathol Lab Med. 1995;119(6):528–532.
  • Caraballo-Arias Y, Caffaro P, Boffetta P, Violante FS. Quantitative Assessment of Asbestos Fibers in Normal and Pathological Pleural Tissue-A Scoping Review. Life (Basel). 2022;12(2):296. doi:10.3390/life12020296.
  • Nenadic CM, Crable JV. Enzymatic digestion of human lung tissue. Am Ind Hyg Assoc J. 1970;31(1):81–86. doi:10.1080/0002889708506211.
  • Jaunarajs KL, Liebling RS. The digestion of lung tissue for mineral dust recovery. Am Ind Hyg Assoc J. 1972;33(8):535–542. doi:10.1080/0002889728506701.
  • Pooley FD. Tissue mineral identification. In: Weill H, Turner-Warwick M, eds. Occupational Lung Diseases. Research Approaches and Methods. New York, NY: Marcel Decker; 1981. p. 189–235.
  • Ashcroft T, Heppleston AG. The optical and electron microscopic determination of pulmonary asbestos fibre concentration and its relation to the human pathological reaction. J Clin Pathol. 1973;26(3):224–234. doi:10.1136/jcp.26.3.224.
  • Churg A, Wright JL, DePaoli L, Wiggs B. Mineralogic correlates of fibrosis in chrysotile miners and millers. Am Rev Respir Dis. 1989;139(4):891–896. doi:10.1164/ajrccm/139.4.891.
  • Roggli VL, Pratt PC. Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests. Hum Pathol. 1983;14(4):355–361. doi:10.1016/s0046-8177(83)80122-1.
  • Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med. 1982;106(11):544–596.
  • Monsó E, Texidó A, Lopez D, et al. Asbestos bodies in normal lung of western Mediterranean populations with no occupational exposure to inorganic dust. Arch Environ Health. 1995;50(4):305–311. doi:10.1080/00039896.1995.9935959.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.